Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Michael C. John

Everolimus-Eluting Stents Improve Vascular Response in a Diabetic Animal Model

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2014English

Related publications

Role of Drug Eluting Stents in Diabetic Patients

Heart
Cardiovascular MedicineCardiology
2006English

Biodegradable-Polymer Biolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study

Texas Heart Institute Journal
MedicineCardiovascular MedicineCardiology
2016English

Initial Pathological Responses of Second-Generation Everolimus-Eluting Stents Implantation in Japanese Coronary Arteries: Comparison With First-Generation Sirolimus-Eluting Stents

Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Long-Term Comparison of Everolimus-Eluting Stents With Sirolimus- And Paclitaxel-Eluting Stents for Percutaneous Coronary Intervention of Saphenous Vein Grafts

EuroIntervention
MedicineCardiovascular MedicineCardiology
2014English

Chronic Total Occlusion Successfully Treated With a Bioresorbable Everolimus-Eluting Vascular Scaffold

Postepy w Kardiologii Interwencyjnej
Cardiovascular MedicineCardiology
2014English

Clinical Outcomes of Bioabsorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: Two-Year Follow-Up of the DESSOLVE III Trial

EuroIntervention
MedicineCardiovascular MedicineCardiology
2020English

Bioresorbable Vascular Stents and Drug-Eluting Stents in Treatment of Coronary Heart Disease: A Meta-Analysis

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2020English

Pharmacokinetic Analysis After Implantation of Everolimus-Eluting Self-Expanding Stents in the Peripheral Vasculature

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2012English

Hybrid Coronary Percutaneous Treatment With Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results From the GABI-R Registry

Journal of Clinical Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy